Aripiprazole Accord Healthcare 10mg Orodispersible Tablets Malta - English - Medicines Authority

aripiprazole accord healthcare 10mg orodispersible tablets

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - aripiprazole - orodispersible tablet - aripiprazole 10 mg - psycholeptics

Aripiprazole Accord Healthcare 15mg Orodispersible Tablets Malta - English - Medicines Authority

aripiprazole accord healthcare 15mg orodispersible tablets

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - aripiprazole - orodispersible tablet - aripiprazole 15 mg - psycholeptics

Aripiprazole Accord Healthcare 30mg Orodispersible Tablets Malta - English - Medicines Authority

aripiprazole accord healthcare 30mg orodispersible tablets

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - aripiprazole - orodispersible tablet - aripiprazole 30 mg - psycholeptics

CABAZITAXEL ACCORD cabazitaxel 60 mg/3 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cabazitaxel accord cabazitaxel 60 mg/3 ml concentrated injection vial

accord healthcare pty ltd - cabazitaxel, quantity: 60 mg - injection, concentrated - excipient ingredients: polysorbate 80; ethanol absolute - cabazitaxel accord in combination with prednisone or prednisolone is indicated for the treatment of patients with metastatic castration resistant prostate cancer previously treated with a docetaxel containing regimen. .

CISPLATIN ACCORD cisplatin 25 mg/25 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cisplatin accord cisplatin 25 mg/25 ml concentrated injection vial

accord healthcare pty ltd - cisplatin, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - cisplatin accord may be used as a monotherapy or in combination with other chemotherapeutic agents in the treatment of:,? metastatic non-seminomatous germ cell carcinoma,? advanced stage, refractory ovarian carcinoma,? advanced stage, refractory bladder carcinoma,? refractory squamous cell carcinoma of the head and neck

CISPLATIN ACCORD cisplatin 100 mg/100 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cisplatin accord cisplatin 100 mg/100 ml concentrated injection vial

accord healthcare pty ltd - cisplatin, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: sodium hydroxide; sodium chloride; water for injections; hydrochloric acid - cisplatin accord may be used as a monotherapy or in combination with other chemotherapeutic agents in the treatment of:,? metastatic non-seminomatous germ cell carcinoma,? advanced stage, refractory ovarian carcinoma,? advanced stage, refractory bladder carcinoma,? refractory squamous cell carcinoma of the head and neck

CISPLATIN ACCORD cisplatin 10 mg/10 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cisplatin accord cisplatin 10 mg/10 ml concentrated injection vial

accord healthcare pty ltd - cisplatin, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - cisplatin accord may be used as a monotherapy or in combination with other chemotherapeutic agents in the treatment of:,? metastatic non-seminomatous germ cell carcinoma,? advanced stage, refractory ovarian carcinoma,? advanced stage, refractory bladder carcinoma,? refractory squamous cell carcinoma of the head and neck

CISPLATIN ACCORD cisplatin 50 mg/50 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cisplatin accord cisplatin 50 mg/50 ml concentrated injection vial

accord healthcare pty ltd - cisplatin, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: sodium chloride; sodium hydroxide; water for injections; hydrochloric acid - cisplatin accord may be used as a monotherapy or in combination with other chemotherapeutic agents in the treatment of:,? metastatic non-seminomatous germ cell carcinoma,? advanced stage, refractory ovarian carcinoma,? advanced stage, refractory bladder carcinoma,? refractory squamous cell carcinoma of the head and neck

LIDOCAINE ACCORD 1% lidocaine hydrochloride 20 mg/2 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine accord 1% lidocaine hydrochloride 20 mg/2 ml injection ampoule

accord healthcare pty ltd - lidocaine hydrochloride, quantity: 20 mg - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; sodium chloride; water for injections - lidocaine accord solutions are indicated for the production of local or regional anaesthesia by the following techniques: ? infiltration ? intravenous regional anaesthesia ? peripheral nerve block ? epidural block ? subarachnoid block

LIDOCAINE ACCORD 2% lidocaine hydrochloride 40 mg/2 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine accord 2% lidocaine hydrochloride 40 mg/2 ml injection ampoule

accord healthcare pty ltd - lidocaine hydrochloride, quantity: 40 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - lidocaine accord solutions are indicated for the production of local or regional anaesthesia by the following techniques: ? infiltration ? intravenous regional anaesthesia ? peripheral nerve block ? epidural block ? subarachnoid block